CPT + Memory Enhancement for PTSD
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to improve therapy for older adults with PTSD (posttraumatic stress disorder), a condition affecting feelings after traumatic events. It focuses on Cognitive Processing Therapy (CPT) and examines whether adding memory support can help participants remember and learn from therapy sessions more effectively. The trial seeks veterans over 59 diagnosed with PTSD who are not using certain medications or have other specific conditions. By enhancing memory during therapy, the trial aims to boost the effectiveness of PTSD treatment. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance PTSD therapy for older adults.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you use benzodiazepines daily.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Cognitive Processing Therapy (CPT) effectively treats PTSD. Participants often experience significant relief from PTSD symptoms, as well as from depression and anxiety, suggesting that the therapy is generally manageable.
The added memory support aims to enhance patients' recall and understanding of the therapy. While this aspect is still under investigation, CPT alone has demonstrated positive results across different settings and groups. Specific information on side effects from the memory support addition is not yet available, but CPT itself is known to be safe.12345Why are researchers excited about this trial?
Researchers are excited about combining Cognitive Processing Therapy (CPT) with Memory Enhancement for PTSD because it introduces strategies specifically designed to boost learning and memory of therapeutic content. Unlike standard CPT, which focuses on processing trauma-related thoughts and feelings, this enhanced version aims to solidify the therapy's impact by improving how patients retain and apply what they learn. This dual approach could lead to more effective and lasting relief from PTSD symptoms, offering hope for improved recovery outcomes.
What evidence suggests that this trial's treatments could be effective for PTSD?
Research shows that Cognitive Processing Therapy (CPT), one of the treatments in this trial, effectively reduces PTSD symptoms. Studies indicate that CPT not only helps with PTSD but also improves depression, anxiety, and overall quality of life. In this trial, some participants will receive CPT with Memory Support. Early findings suggest this addition might enhance CPT's effectiveness by helping patients better remember and learn from therapy sessions. This could be especially beneficial for older adults who may experience memory difficulties. Overall, CPT with Memory Support aims to address memory issues that can sometimes limit therapy's success.56789
Who Is on the Research Team?
James C. Scott, PhD
Principal Investigator
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
Are You a Good Fit for This Trial?
This trial is for veterans over the age of 59 with PTSD diagnosed by a specific scale (CAPS-5). It's not suitable for those with severe brain injury, dementia signs, daily benzodiazepine use, bipolar or psychotic disorders, current serious suicidal thoughts, active substance abuse issues not in remission for at least a month, or other limiting conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Cognitive Processing Therapy (CPT) with or without Memory Support to enhance learning and memory of therapy content
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Processing Therapy
- Cognitive Processing Therapy (CPT) + Memory Support
Cognitive Processing Therapy is already approved in United States, European Union for the following indications:
- Posttraumatic Stress Disorder (PTSD)
- Posttraumatic Stress Disorder (PTSD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor